Unidoc arranges $1.5-million private placement

Executive Summary

• Unidoc Health Corp. announced a non‑brokered private placement (listed issuer financing exemption) to raise up to $1.5 million by issuing up to 10 million units at $0.15 per unit.
• Each unit consists of one common share and one transferable warrant allowing purchase of an additional share at $0.25 for 36 months after closing.
• Proceeds will be used for inventory, marketing, investor‑relations services, working capital, and general corporate purposes; the offering is expected to close on or about Oct 15 2025 (or within 45 days of Oct 2 2025).

Key Details

• Offering Size: Up to $1.5 million gross proceeds.
• Units Offered: Up to 10 million units at $0.15 per unit.
• Unit Composition:
• 1 common share of Unidoc Health Corp.
• 1 transferable common‑share purchase warrant (exercise price $0.25, exercisable for 36 months post‑closing).
• Use of Proceeds: Inventory, marketing and investor‑relations services, working capital, and general corporate purposes.
• Exemption Used: Listed issuer financing exemption under Part 5A of NI 45‑106 (prospectus exempt) – offered in all Canadian provinces/territories except Quebec.
• Resale Restrictions: Securities issued to Canadian resident subscribers are not subject to resale restrictions per NI 45‑106.
• Closing Date: Expected on or about Oct 15 2025, or any date within 45 days of Oct 2 2025, subject to customary conditions and CSE approval.
• Documentation: Offering document available on SEDAR+ and the company’s website; prospective investors urged to review it before investing.

Notable Quotes

(No direct quotes provided in the release.)